Argentina's population was heavily affected by the 2009 influenza pandemic, particularly children, in whom incidence of seasonal influenza is consistently high. Following the pandemic, Argentinean national recommendations for pediatric vaccination against A/H1N1 influenza were defined for all children aged up to five years, in line with programs implemented by national authorities elsewhere. Economic evaluations have found that vaccination programs for this population against seasonal influenza are cost-effective, if not cost-saving in many countries. Recently, Argentina decided to routinely vaccinate against influenza children aged 6-23 mo-old. But, the economic value of such strategies for the country has never been assessed.
CITATION STYLE
Giglio, N., Gentile, A., Lees, L., Micone, P., Armoni, J., Reygrobellet, C., & Crepey, P. (2012). Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. Human Vaccines & Immunotherapeutics, 8(3), 312–322. https://doi.org/10.4161/hv.18569
Mendeley helps you to discover research relevant for your work.